Nuo Therapeutics, Inc. SEC filings AURX
Nuo Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 8, 2005. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (material agreement, new debt, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Aug 4, 2025 | — |
| EFFECT | Filing | May 12, 2025 | — |
| CORRESP | Letter to the SEC | May 8, 2025 | — |
| UPLOAD | Letter from the SEC | May 6, 2025 | — |
| NT 10-K | Form nt 10-k | Apr 1, 2025 | Dec 31, 2024 |
| D | Filing | Sep 23, 2024 | — |
| D | Filing | May 22, 2024 | — |
| NT 10-K | Form nt 10-k | Apr 1, 2024 | Dec 31, 2023 |
| D | Filing | Dec 22, 2023 | — |
| NT 10-Q | Form nt 10-q | Nov 15, 2023 | Sep 30, 2023 |
| D | Filing | Aug 8, 2023 | — |
| NT 10-K | Form nt 10-k | Mar 31, 2023 | Dec 31, 2022 |
| D | Filing | May 19, 2022 | — |
| D | Filing | May 6, 2022 | — |
| NT 10-K | Form nt 10-k | Mar 31, 2022 | Dec 31, 2021 |
| SC TO-T/A | Final amendment | Mar 21, 2022 | — |
| SC 14D9 | Schedule 14d9 | Feb 4, 2022 | — |
| SC TO-T | Schedule to | Jan 21, 2022 | — |
| NT 10-Q | Form nt 10-q | Nov 13, 2019 | Sep 30, 2019 |
| NT 10-Q | Form nt 10-q | Aug 14, 2019 | Jun 30, 2019 |
| NT 10-Q | Form nt 10-q | May 15, 2019 | Mar 31, 2019 |
| NT 10-K | Form nt 10-k | Apr 1, 2019 | Dec 31, 2018 |
| NT 10-Q | Form nt 10-q | Nov 14, 2018 | Sep 30, 2018 |
| D | Filing | Jun 12, 2018 | — |
| NT 10-K | Form nt 10-k | Apr 2, 2018 | Dec 31, 2017 |
| RW | Form rw | Aug 4, 2017 | — |
| EFFECT | Filing | Jan 11, 2017 | — |
| CORRESP | Letter to the SEC | Jan 9, 2017 | — |
| CORRESP | Letter to the SEC | Dec 23, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2016 | — |
| NT 10-Q | Form 12b-25 | Aug 12, 2016 | Jun 30, 2016 |
| D | Filing | May 20, 2016 | — |
| NT 10-Q | Form 12b-25 | May 17, 2016 | Mar 31, 2016 |
| 8-A12G | Filing | May 10, 2016 | — |
| NT 10-K | Form 12b-25 | Mar 31, 2016 | Dec 31, 2015 |
| EFFECT | Filing | Jun 22, 2015 | — |
| EFFECT | Filing | May 13, 2015 | — |
| EFFECT | Filing | Aug 12, 2014 | — |
| CORRESP | Letter to the SEC | Aug 11, 2014 | — |
| CORRESP | Letter to the SEC | Jul 28, 2014 | — |
| EFFECT | Filing | May 9, 2014 | — |
| EFFECT | Filing | May 9, 2014 | — |
| EFFECT | Filing | May 9, 2014 | — |
| EFFECT | Filing | May 9, 2014 | — |
| EFFECT | Filing | Jan 24, 2014 | — |
| D | Filing | Dec 10, 2013 | — |
| EFFECT | Filing | Jul 17, 2013 | — |
| EFFECT | Filing | Jul 17, 2013 | — |
| EFFECT | Filing | Jul 17, 2013 | — |
| CORRESP | Letter to the SEC | Jul 15, 2013 | — |
| CORRESP | Letter to the SEC | Jul 1, 2013 | — |
| CORRESP | Letter to the SEC | Jul 1, 2013 | — |
| CORRESP | Letter to the SEC | Jul 1, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2013 | — |
| CORRESP | Letter to the SEC | Jun 12, 2013 | — |
| CORRESP | Letter to the SEC | Jun 12, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2013 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2013 | — |
| EFFECT | Filing | Nov 8, 2012 | — |
| EFFECT | Filing | Nov 8, 2012 | — |
| CORRESP | Letter to the SEC | Nov 6, 2012 | — |
| CORRESP | Letter to the SEC | Nov 6, 2012 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2012 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2012 | — |
| UPLOAD | Letter from the SEC | Aug 24, 2012 | — |
| CORRESP | Letter to the SEC | Aug 14, 2012 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2012 | — |
| POS EX | Form pos ex | Apr 19, 2012 | — |
| POS EX | Form pos ex | Apr 19, 2012 | — |
| POS EX | Form pos ex | Apr 19, 2012 | — |
| EFFECT | Filing | Apr 17, 2012 | — |
| EFFECT | Filing | Apr 17, 2012 | — |
| EFFECT | Filing | Apr 17, 2012 | — |
| D | Filing | Feb 15, 2012 | — |
| EFFECT | Filing | Nov 1, 2011 | — |
| CORRESP | Letter to the SEC | Oct 31, 2011 | — |
| CORRESP | Letter to the SEC | Oct 26, 2011 | — |
| UPLOAD | Letter from the SEC | Oct 19, 2011 | — |
| D | Filing | Jul 26, 2011 | — |
| D | Filing | Jul 26, 2011 | — |
| EFFECT | Filing | Jul 22, 2011 | — |
| RW | Filing | Jul 18, 2011 | — |
| EFFECT | Filing | May 6, 2011 | — |
| D | Filing | May 4, 2011 | — |
| 25-NSE | Delisting notice | Feb 28, 2011 | — |
| EFFECT | Filing | Jan 26, 2011 | — |
| EFFECT | Filing | Dec 8, 2010 | — |
| EFFECT | Filing | Nov 3, 2010 | — |
| CORRESP | Letter to the SEC | Nov 1, 2010 | — |
| D | Filing | Oct 19, 2010 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2010 | — |
| D | Filing | Apr 22, 2010 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2009 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2009 | — |
| CORRESP | Letter to the SEC | Aug 28, 2009 | — |
| CORRESP | Letter to the SEC | Aug 10, 2009 | — |
| EFFECT | Filing | Mar 28, 2008 | — |
| NT 10-Q | Filing | Nov 9, 2007 | Sep 30, 2007 |
| UPLOAD | Letter from the SEC | Oct 2, 2007 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2007 | — |
| CORRESP | Letter to the SEC | Sep 10, 2007 | — |
| CORRESP | Letter to the SEC | Aug 17, 2007 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2007 | — |
| 10KSB | Filing | Mar 23, 2006 | Dec 31, 2005 |
| 10QSB | Filing | Nov 9, 2005 | Sep 30, 2005 |
| 10QSB | Filing | Aug 15, 2005 | Jun 30, 2005 |
Showing 107 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- AURX (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1091596
- Former names
- Nuo Therapeutics, Inc (until Dec 23, 2014); CYTOMEDIX INC (until Oct 8, 2014); AUTOLOGOUS WOUND THERAPY INC (until Apr 10, 2000); AUTOLOGOUS WOUND TRERAPY INC (until Mar 23, 2000)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.